A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19

BACKGROUND: Although convalescent plasma has been widely used to treat severe coronavirus disease 2019 (COVID-19), data from randomized controlled trials that support its efficacy are limited. METHODS: We conducted a randomized, double-blind, controlled trial among adults hospitalized with severe an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Invest
Main Authors: O’Donnell, Max R., Grinsztejn, Beatriz, Cummings, Matthew J., Justman, Jessica E., Lamb, Matthew R., Eckhardt, Christina M., Philip, Neena M., Cheung, Ying Kuen, Gupta, Vinay, João, Esau, Pilotto, Jose Henrique, Diniz, Maria Pia, Cardoso, Sandra Wagner, Abrams, Darryl, Rajagopalan, Kartik N., Borden, Sarah E., Wolf, Allison, Sidi, Leon Claude, Vizzoni, Alexandre, Veloso, Valdilea G., Bitan, Zachary C., Scotto, Dawn E., Meyer, Benjamin J., Jacobson, Samuel D., Kantor, Alex, Mishra, Nischay, Chauhan, Lokendra V., Stone, Elizabeth F., Dei Zotti, Flavia, La Carpia, Francesca, Hudson, Krystalyn E., Ferrara, Stephen A., Schwartz, Joseph, Stotler, Brie A., Lin, Wen-Hsuan W., Wontakal, Sandeep N., Shaz, Beth, Briese, Thomas, Hod, Eldad A., Spitalnik, Steven L., Eisenberger, Andrew, Lipkin, Walter I.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2021
Assuntos:
Clinical Medicine
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8245169/
https://ncbi.nlm.nih.gov/pubmed/33974559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI150646
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados